The offer is available to insured people and applies to both the injection and oral versions
And I'm lecturing to myself truthfully, ladies, because I struggle with this, too
Do not have contraindications such as certain gastrointestinal disorders or severe endocrine conditions
In its pivotal Phase 3 ATTAIN-1 trial, which involved over 3,000 adults with obesity or overweight, orforglipron demonstrated significantly higher weight loss compared to a placebo
Use of GLP-1 agonists can result in large reductions in hunger and food cravings, increased fullness and satiety, and better control of eating
His mix of longevity, performance, and brain-boosting products reflects his obsession with health and fitness